Financing ·
On August 3, 2026, Park Ha Biological Technology Co., Ltd. completed a private placement transaction with non-U.S.…
BYAHPark Ha Biological Technology Co., Ltd.
On August 3, 2026, Park Ha Biological Technology Co., Ltd. completed a private placement transaction with non-U.S. investors, issuing 10,000,000 Class A ordinary shares and warrants to purchase up to 2,000,000 additional shares. The securities were sold at $0.18 per share and accompanying warrant, generating approximately $1,800,000 in aggregate gross proceeds before offering expenses. The warrants are immediately exercisable for five years at an exercise price of $0.18 per share. The company intends to use the net proceeds for general working capital and corporate purposes. Park Ha Biological Technology Co., Ltd. operates in the biological technology industry.